Kevin Coker: Are Tall Tales Detracting Investors?View All articles
Kevin Coker discusses why tall tales can detract potential in Healthcare Business Today, and the 4 reasons why entrepreneurs can feel compelled to stretch the truth with investors.
Kevin Coker, co-founder and CEO of Proxima Clinical Research shared, "At some point for investors, startup pitches all start to sound the same; like everyone is trying to emulate the next influential person of the year—a charismatic leader with out-of-the-box ideas and foresight into the future. Sadly, many simply don’t understand where their value lies, so they feel the need to create illusions about their business, their milestones, and their progress as a means of telling their story more favorably. This is the worst thing you could do."
It can be challenging in the life-sciences industry to share your product vision and garner investor interest. Kevin reviews in this article the 4 reasons why start-ups stretch the truth of their company to investors - and how to avoid this course of action.